J D Harry

603 total citations
26 papers, 461 citations indexed

About

J D Harry is a scholar working on Cardiology and Cardiovascular Medicine, Physiology and Analytical Chemistry. According to data from OpenAlex, J D Harry has authored 26 papers receiving a total of 461 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cardiology and Cardiovascular Medicine, 5 papers in Physiology and 5 papers in Analytical Chemistry. Recurrent topics in J D Harry's work include Cardiac electrophysiology and arrhythmias (7 papers), Analytical Methods in Pharmaceuticals (5 papers) and Pharmacological Effects and Assays (4 papers). J D Harry is often cited by papers focused on Cardiac electrophysiology and arrhythmias (7 papers), Analytical Methods in Pharmaceuticals (5 papers) and Pharmacological Effects and Assays (4 papers). J D Harry collaborates with scholars based in United Kingdom, United States and Ireland. J D Harry's co-authors include R. J. Linden, G.G. Brownlee, Golitsyn Sp, P Touboul, H. M. Snow, Marc A. Vos, Gerhard Steinbeck, M. Ya. Ruda, Karl Stangl and Kimberly T. Perry and has published in prestigious journals such as The Journal of Physiology, Antimicrobial Agents and Chemotherapy and British Journal of Pharmacology.

In The Last Decade

J D Harry

23 papers receiving 386 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J D Harry United Kingdom 11 226 85 65 65 49 26 461
Peter E. Dresel Canada 15 329 1.5× 189 2.2× 65 1.0× 84 1.3× 63 1.3× 67 624
WH Aellig Japan 9 202 0.9× 66 0.8× 30 0.5× 114 1.8× 115 2.3× 10 452
Clinton B. Nash United States 10 163 0.7× 126 1.5× 50 0.8× 30 0.5× 47 1.0× 35 357
J Yelnosky United States 10 48 0.2× 85 1.0× 77 1.2× 56 0.9× 62 1.3× 31 338
WG Nayler Australia 8 204 0.9× 126 1.5× 46 0.7× 36 0.6× 39 0.8× 10 360
C.E. Powell United States 4 77 0.3× 103 1.2× 47 0.7× 48 0.7× 31 0.6× 9 319
Annhild Larsson Sweden 8 53 0.2× 79 0.9× 32 0.5× 226 3.5× 67 1.4× 9 558
J. D. Fitzgerald Canada 10 157 0.7× 71 0.8× 24 0.4× 74 1.1× 35 0.7× 25 360
A Hedges United Kingdom 10 30 0.1× 69 0.8× 51 0.8× 49 0.8× 40 0.8× 32 325
Ahmad Al‐Saffar Sweden 11 96 0.4× 121 1.4× 84 1.3× 65 1.0× 60 1.2× 17 344

Countries citing papers authored by J D Harry

Since Specialization
Citations

This map shows the geographic impact of J D Harry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J D Harry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J D Harry more than expected).

Fields of papers citing papers by J D Harry

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J D Harry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J D Harry. The network helps show where J D Harry may publish in the future.

Co-authorship network of co-authors of J D Harry

This figure shows the co-authorship network connecting the top 25 collaborators of J D Harry. A scholar is included among the top collaborators of J D Harry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J D Harry. J D Harry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schneider, M. M. E., et al.. (1995). Safety, tolerance, and pharmacokinetics of atevirdine mesylate (U-87201E) in asymptomatic human immunodeficiency virus-infected patients. Antimicrobial Agents and Chemotherapy. 39(3). 602–607. 10 indexed citations
2.
Donaldson, Kirsteen, et al.. (1994). The effect fluvoxamine at steady state on the pharmacokinetics of theophylline after a singe dose in healthy male volunteers. British Journal of Clinical Pharmacology. 37(5). 492. 3 indexed citations
3.
Harry, J D. (1989). Clinical Pharmacology of Epanolol Pharmacodynamic Aspects. Drugs. 38(Supplement 2). 18–27. 5 indexed citations
4.
Webster, John, et al.. (1988). Effects of the beta 2‐adrenoceptor antagonist ICI 118,551 on blood pressure in hypertensive patients known to respond to beta 1‐ adrenoceptor antagonists.. British Journal of Clinical Pharmacology. 25(4). 433–438. 12 indexed citations
5.
REID, WILLIAM D., et al.. (1987). Effects of beta‐adrenoceptor blockade on heart rate and physiological tremor in diabetics with autonomic neuropathy. A comparative study of epanolol, atenolol and pindolol.. British Journal of Clinical Pharmacology. 23(4). 383–389. 6 indexed citations
6.
Harry, J D, et al.. (1985). Experience with a Doppler technique to investigate the interaction of isoprenaline and various B-adrenoceptor blocking drugs on blood vessels in the lower limb. European Journal of Clinical Pharmacology. 29(4). 447–454. 1 indexed citations
7.
Marshall, A., et al.. (1979). Dose response for blood pressure and degree of cardiac beta-blockade with atenolol. Postgraduate Medical Journal. 55(646). 537–540. 11 indexed citations
8.
Jackson, Graham, J D Harry, Christine Robinson, David H. Kitson, & D. E. Jewitt. (1978). Comparison of atenolol with propranolol in the treatment of angina pectoris with special reference to once daily administration of atenolol.. Heart. 40(9). 998–1004. 32 indexed citations
9.
Harry, J D. (1976). Evaluation of intrinsic sympathomimetic activity of beta-adrenoceptor blocking drugs in the treatment of patients with angina pectoris.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 172–82. 1 indexed citations
10.
Harry, J D, et al.. (1974). Proceedings: Antagonism by ICI 66082 of the effects of electrical stimulation on the right ansa subclavia of the dog.. PubMed. 50(3). 457P–458P. 5 indexed citations
11.
Harry, J D, C. T. Kappagoda, R. J. Linden, & H. M. Snow. (1973). Action of propranolol on the dog heart. Cardiovascular Research. 7(6). 729–739. 26 indexed citations
12.
Harry, J D, et al.. (1973). The action of ICI-66082 on the heart.. PubMed. 48(2). 340P–341P. 13 indexed citations
13.
Harry, J D, R. J. Linden, & H. M. Snow. (1972). FLUID MIXING III. British Journal of Pharmacology. 45(1). 155P–156P. 1 indexed citations
14.
Harry, J D, et al.. (1972). PROCEEDINGS OF THE ANAESTHETIC RESEARCH SOCIETY LONDON HOSPITAL MEETING: APRIL 14, 197: Abstracts of work completed and in progress. British Journal of Anaesthesia. 44(6). 620–626. 2 indexed citations
15.
Harry, J D, R. J. Linden, & H. M. Snow. (1971). Effects of -adrenoreceptor blocking drugs on isolated skeletal and cardiac muscle.. PubMed. 43(2). 453P–454P. 3 indexed citations
16.
Harry, J D, C. T. Kappagoda, R. J. Linden, & H. M. Snow. (1971). Depression of the reflex tachycardia from the left atrial receptors by acidaemia. The Journal of Physiology. 218(2). 465–475. 9 indexed citations
17.
Harry, J D, C. T. Kappagoda, R. J. Linden, & H. M. Snow. (1971). Effects of beta-adrenoceptor blocking drugs on the chronotropic and inotropic actions of isoprenaline on the acutely denervated dog heart.. PubMed. 41(2). 387P–389P. 2 indexed citations
18.
Harry, J D & V. R. Pickles. (1968). A METHOD OF RECORDING MYOMETRIAL CONTRACTIONS IN THE NON-PREGNANT RHESUS MONKEY IN VIVO. Journal of Endocrinology. 41(1). 105–NP. 3 indexed citations
19.
Harry, J D. (1964). The site of action of sympathomimetic amines on the circular muscle strip from the guinea-pig isolated ileum. Journal of Pharmacy and Pharmacology. 16(5). 332–336. 5 indexed citations
20.
Brownlee, G.G. & J D Harry. (1963). SOME PHARMACOLOGICAL PROPERTIES OF THE CIRCULAR AND LONGITUDINAL MUSCLE STRIPS FROM THE GUINEA‐PIG ISOLATED ILEUM. British Journal of Pharmacology and Chemotherapy. 21(3). 544–554. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026